Tokyo, Nov. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059711) titled 'Diagnostic Accuracy of the Bowel Wall Flow Assessed by MV-Flow in Detecting Inflammation Severity in Ulcerative Colitis: A Comparative Study with Endoscopic Severity (FLOW Trial)' on Nov. 10.
Study Type:
Observational
Primary Sponsor:
Institute - Kitasato University Kitasato Institute Hospital
Condition:
Condition - Ulcerative colitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to compare the modified Limberg score with the newly developed MV Flow score for assessing disease severity in UC using MV flow technology. The goal is to determine whether MV flow can offer superior diagnostic accuracy and better reflect the inflammatory status of the intestinal mucosa.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 15
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Consecutive patients more than 15 years old who have a UC undergoing endoscopy for evaluation of disease activity or surveillance were eligible for inclusion.
Key exclusion criteria - If there was a change in treatment or symptoms between IUS and endoscopy, patients were excluded. Patients with a history of total colectomy and pregnant women were also excluded.
Target Size - 70
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2024 Year 08 Month 01 Day
Date of IRB - 2024 Year 08 Month 01 Day
Anticipated trial start date - 2024 Year 08 Month 01 Day
Last follow-up date - 2025 Year 10 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068163
Disclaimer: Curated by HT Syndication.
